4//SEC Filing
McCartney Michael Brian 4
Accession 0001493152-18-013540
CIK 0001349929other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 4:05 PM ET
Size
6.1 KB
Accession
0001493152-18-013540
Insider Transaction Report
Form 4
McCartney Michael Brian
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2018-08-15+100,000→ 100,000 totalExercise: $1.03Exp: 2028-08-15→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Amended and Restated Cancer Genetics, Inc. 2011 Equity Incentive Plan (the "2011 Plan"). The shares underlying the options shall become vested and exercisable with respect to twenty percent (20%) of the shares on the one-year anniversary of the date of grant and with respect to the remaining eighty percent (80%) of the shares in equal monthly installments on the 15th day of each of the forty-eight (48) calendar months thereafter, provided that the optionee remains a services provider to the Company through each applicable vesting period. The exercise price is the closing price of a share of Common Stock as of the date of grant on the NASDAQ Capital Market in accordance with the terms of the 2011 Plan.
Documents
Issuer
CANCER GENETICS, INC
CIK 0001349929
Entity typeother
Related Parties
1- filerCIK 0001743965
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 4:05 PM ET
- Size
- 6.1 KB